07:00 , Jul 25, 1994 |  BC Week In Review  |  Company News

Lidak deal

Boryung Pharmaceuticals Co. Ltd. received a license for the Korean development of Lidakol, LDAKA's anti-viral compound to treat herpes. Boryung will be responsible for regulatory approval, marketing and manufacturing of Lidakol for topical indications in...